Cargando…
Recent Advances in Allergen-Specific Immunotherapy in Humans: A Systematic Review
Allergen-specific immunotherapy (AIT) is presumed to modulate the natural course of allergic disease by inducing immune tolerance. However, conventional AITs, such as subcutaneous immunotherapy and sublingual immunotherapy, require long treatment durations and often provoke local or systemic hyperse...
Autores principales: | Lee, Sang Pyo, Shin, Yoo Seob, Kang, Sung-Yoon, Kim, Tae-Bum, Lee, Sang Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Immunologists
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901700/ https://www.ncbi.nlm.nih.gov/pubmed/35291653 http://dx.doi.org/10.4110/in.2022.22.e12 |
Ejemplares similares
-
Allergen-specific intralymphatic immunotherapy in human and animal studies
por: Kim, Seon Tae, et al.
Publicado: (2017) -
Factors Associated with Adherence to Allergen Specific Subcutaneous Immunotherapy
por: Lee, Ji-Ho, et al.
Publicado: (2019) -
Clinical Efficacy of Allergen-Specific Immunotherapy from Patient and Physician Perspectives
por: Shin, Yoo Seob, et al.
Publicado: (2019) -
KAAACI Guidelines for Allergen Immunotherapy
por: Lee, Hwa Young, et al.
Publicado: (2023) -
Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial
por: Park, Hye Jung, et al.
Publicado: (2021)